2025 American Academy of Neurology Abstract Website

Disclosures for "Genomic Medicine for Alzheimer’s Disease"

Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Dr. Al-Ramahi has nothing to disclose.
The institution of Dr. Botas has received research support from NIH.
Miss Chavez has nothing to disclose.
Mrs. carter has nothing to disclose.
The institution of Sarah Elsea has received research support from NIH. The institution of Sarah Elsea has received research support from Speragen, Inc. The institution of Sarah Elsea has received research support from PTC Therapeutics, Inc. The institution of Sarah Elsea has received research support from PRISMS, Inc. The institution of Sarah Elsea has received research support from Warren Alpert Foundation. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Reviewer with CDMRP-DOD.
Ms. Etoundi has received personal compensation for serving as an employee of Baylor College of Medicine.
Ms. Fong has nothing to disclose.
Dr. Franco Pando has nothing to disclose.
Dr. Hamdan has nothing to disclose.
Dr. Hu has nothing to disclose.
Dr. Jackson has nothing to disclose.
The institution of Dr. Lee has received research support from NIA.
Prof. Lichtarge has nothing to disclose.
Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Zhandong Liu has nothing to disclose.
Miss Lozano has nothing to disclose.
Dr. Maletic-Savatic has nothing to disclose.
The institution of Dr. Malek has received research support from National Institutes of Health.
Miss Matute has nothing to disclose.
Dr. McGuire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nurture Genomics. Dr. McGuire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lykos Therapeutics. Dr. McGuire has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Greenwall Foundation. Dr. McGuire has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for King and Spalding. The institution of Dr. McGuire has received research support from NIH. The institution of Dr. McGuire has received research support from Fidelity. The institution of Dr. McGuire has received research support from Ortus Foundation.
The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Ms. MUZNY has received personal compensation in the range of $0-$499 for serving as a study section review with nih.
The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Dr. Rizk has stock in BOC Ventures XIX, LP (Gecko RObotics). Dr. Rizk has stock in BOC Ventures XXII, LP (x.AI).
Ms. Robinson has nothing to disclose.
Ms. Saade has nothing to disclose.
Prof. Shaw has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Texas Genomics Consulting. Prof. Shaw has stock in Texas Genomics Consulting.
Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Illumina, Inc.
Dr. Sober has nothing to disclose.
Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Toledo Atucha has received personal compensation in the range of $0-$499 for serving as a Consultant for SpearBio. Dr. Toledo Atucha has received personal compensation in the range of $0-$499 for serving as a Consultant for Newell. Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Toledo Atucha has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EISAI.
The institution of Dr. Vanegas-Arroyave has received research support from National Institutes of Health. The institution of Dr. Vanegas-Arroyave has received research support from MJFF.
Dr. Venner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Illumina Inc. Dr. Venner has stock in Juniper Genomics. Dr. Venner has stock in Codified Genomics.
Miss Walker has nothing to disclose.
An immediate family member of Dr. Yu has received personal compensation for serving as an employee of CVS/Aetna. The institution of Dr. Yu has received research support from Alzheimer's Association. The institution of Dr. Yu has received research support from Biogen. The institution of Dr. Yu has received research support from Eisai. The institution of Dr. Yu has received research support from Novo Nordisk. The institution of Dr. Yu has received research support from Suven. The institution of Dr. Yu has received research support from AriBio.
Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genetics in Medicine Open.
Dr. Zoghbi has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TCG. Dr. Zoghbi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cajal Neuroscience. Dr. Zoghbi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian. The institution of Dr. Zoghbi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogene. Dr. Zoghbi has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Regeneron. The institution of Dr. Zoghbi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annual Review of Neuroscience . The institution of Dr. Zoghbi has received research support from Ionis. The institution of Dr. Zoghbi has received research support from UCB. Dr. Zoghbi has received intellectual property interests from a discovery or technology relating to health care. Dr. Zoghbi has received publishing royalties from a publication relating to health care.
Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.